Literature DB >> 1192355

Medullary carcinoma of the thyroid. Cellular immune response to tumor antigen in a heritable human cancer.

J M George, M A Williams, R Almoney, G Sizemore.   

Abstract

We have found inhibition of mononuclear leukocyte migration in response to tumor antigen in a group of patients with medullary carcinoma of the thyroid, a cancer inherited as an autosomal dominant. This immune response was not present in a group of family members who do not have cancer.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1192355     DOI： 10.1002/1097-0142(197511)36:5<1658::aid-cncr2820360519>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.

Authors:  Antonio Matrone; Carla Gambale; Alessandro Prete; Rossella Elisei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 6.055

Review 2.  Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.

Authors:  Jena D French
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

Review 3.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25

4.  A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.

Authors:  Jaydira Del Rivero; Renee N Donahue; Jennifer L Marté; Ann W Gramza; Marijo Bilusic; Myrna Rauckhorst; Lisa Cordes; Maria J Merino; William L Dahut; Jeffrey Schlom; James L Gulley; Ravi A Madan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-07       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.